Advertisement
Screener

Gyre Therapeutics, Inc. (GYRE) Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31)

1.5 / 5 stars · 17/57 Roast Me

Gyre Therapeutics, Inc. Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31)

Gyre Therapeutics, Inc. (GYRE) reported Defined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) of 4.00% for the 12-month period ending 2012-12-31, per its 10-K filed 2013-03-15.

Discontinued › Notes › Compensation Related Costs

us-gaap:DefinedContributionPlanMaximumAnnualContributionPerEmployeePercent · last filed 2013-03-15

  • Gyre Therapeutics, Inc. defined contribution plan, maximum annual contribution per employee, percent (deprecated 2013-01-31) for fiscal 2012 was 4.00%, a 0.00% change from fiscal 2011.
  • Gyre Therapeutics, Inc. defined contribution plan, maximum annual contribution per employee, percent (deprecated 2013-01-31) for fiscal 2011 was 4.00%, a 0.00% change from fiscal 2010.
  • Gyre Therapeutics, Inc. defined contribution plan, maximum annual contribution per employee, percent (deprecated 2013-01-31) for fiscal 2010 was 4.00%.
Period endDefined Contribution Plan, Maximum Annual Contribution Per Employee, Percent (Deprecated 2013-01-31) 12 month
2012-12-314.00%
10-K · filed 2013-03-15
2011-12-314.00%
10-K · filed 2013-03-15
2010-12-314.00%
10-K · filed 2013-03-15

Similar stocks

Stock NameCountryMarket CapPE Ratio
LEXICON PHARMACEUTICALS, INC. (LXRX)United States$0.823B-17.48
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
GERON CORP (GERN)United States$0.803B-12.14
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78